呼吸道病毒快速分子检测对临床结局与患者管理的影响
该文评述Wabe等在《Journal of Clinical Microbiology》发表的研究,评估对因呼吸道疾病住院的成人使用甲/乙型流感和RSV快速分子检测的影响。快速检测出结果中位时间7.5小时,标准PCR为40.3小时;与标准分子检测相比,快速检测显著缩短住院时间并减少其他微生物学检测数量。作者认为快速PCR检测可使患者更早出院、更多患者在出院前获得结果,从而更快提供适当治疗。
要点
- 快速分子检测出结果中位时间7.5小时,标准PCR为40.3小时。
- 快速检测显著缩短住院时间并减少其他微生物学检测数量。
- 更多患者出院前获得结果,有助于更快提供适当治疗。
核心结论
- 对因呼吸道疾病住院的成人,快速PCR检测甲/乙型流感和RSV可为患者和医院带来获益。
研究设计与样本
- 该文为对Wabe等研究的评述,研究对象为因呼吸道疾病住院的成人,比较快速分子检测与标准PCR检测的影响。
主要发现
- 快速检测出结果中位时间为7.5小时,标准PCR检测为40.3小时。
- 与标准分子检测相比,快速检测显著缩短住院时间并减少其他微生物学检测数量。
- 更多患者在出院前获得检测结果。
临床怎么用
- 对因呼吸道疾病住院的成人,可考虑使用快速分子检测以缩短出结果时间、住院时间并减少其他微生物学检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To determine if rapid molecular testing for respiratory viruses in patients with respiratory illnesses can provide advantages to patients and hospitals, rigorous investigations on the impacts of using these assays are required. Well-conducted studies are needed to inform decisions about implementation of new rapid assays to replace standard molecular testing or to initiate testing in laboratories that are currently not doing molecular tests for respiratory viruses due to the complex nature of standard panels. In this issue of the Journal of Clinical Microbiology, N. Wabe et al. (J Clin Microbiol 57:e01727-18, 2019, https://doi.org/10.1128/JCM.01727-18) report the results of their evaluation of the impact of using a rapid molecular test for influenza A/influenza B and RSV on outcomes for adults hospitalized with respiratory illness. The median time from admission to test result of the rapid test was 7.5 h compared to 40.3 h for the standard PCR assay. Compared to the use of the standard molecular assay, use of a rapid test significantly shortened time in the hospital and reduced the number of other microbiology tests performed. The authors concluded that rapid PCR testing of adults hospitalized with respiratory illnesses could provide benefits to both the patients and the hospital. Patients were able to leave the hospital earlier and a greater proportion of them had received their test results before discharge, which would allow appropriate treatment to be provided more quickly.
引用
- Kuypers J. Impact of Rapid Molecular Detection of Respiratory Viruses on Clinical Outcomes and Patient Management. J Clin Microbiol. 2019. PMID: 30651392. doi:10.1128/JCM.01890-18
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。